期刊
GENETICS AND MOLECULAR RESEARCH
卷 13, 期 3, 页码 5276-5284出版社
FUNPEC-EDITORA
DOI: 10.4238/2014.July.24.6
关键词
Platinum-induced ovarian impairment; Ginkgo flavonoids; Amifostine; Leuprorelin
Platinum-induced ovarian impairment is a consequence of treatment for malignant ovarian tumors. We compared the protective effects of Ginkgo flavonoids, amifostine, and leuprorelin on ovarian impairment in rats. Fifty rats were randomly divided into the A, B, C, D, and E groups, which were given saline, cisplatin, cisplatin plus Ginkgo flavonoids, cisplatin plus amifostine, and cisplatin plus leuprorelin, respectively. Ovarian weight was significantly greater in groups C and D compared with group B (83.5 +/- 6.7 and 86.8 +/- 10 vs 56.8 +/- 5.4 mg). The total follicle numbers were higher in groups C, D, and E than in group B (60.5 +/- 3.9, 63.8 +/- 5.1, and 67.7 +/- 3.5 vs 49.6 +/- 4.5), and the apoptotic index was reduced in groups C, D, and E compared with group B (35.7 +/- 2.0, 37.4 +/- 1.6, and 30.5 +/- 2.9 vs 65.3 +/- 2.9%). The ovaries in groups B, C, and D had higher protein and mRNA expression levels of cytoplasmic Cytochrome c (Cyt-c) and apoptotic protease activating factor-1 (Apf-1) compared to group A; the Cyt-c mRNA expression was five-fold higher. The mRNA expression of Cyt-c and Apf-1 were significantly lower in groups C, D, and E compared with group B. Administration of leuprorelin, flavonoids, or amifostine protected rats against the ovarian impairment induced by prior intraperitoneal injection of cisplatin. The efficacy of leuprorelin was superior to that of Ginkgo flavonoids and amifostine, but there was no difference between the effects of Ginkgo flavonoids and amifostine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据